Aqua Bounty Technologies 2Q Net Loss Narrows Slightly As It Awaits FDA Approval for Salmon
SEAFOODNEWS.COM [Dow Jones] - August 4, 2015 -
LONDON, Aqua Bounty Technologies, Inc. today reported a slightly narrowed net loss for the second quarter of the year, and said it continues to receive interest for AquAdvantage Salmon from potential customers both within and outside the U.S.
"We remain hopeful that the FDA will approve AAS [AquAdvantage Salmon] in the near term, and, while we wait for their decision, we are making significant progress with our marketing efforts and preparations in several foreign markets for field trials," Chief Executive Ron Stotish said.
To Read Full Story Login Below.